HTA is still unstructured and nascent in the Indian context
Utkarsh Palnitkar, Partner & Head, Transactions & Restructuring & National Leader - Life sciences practice at KPMG…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Viral hepatitis: The era of molecular assays
Dr Faisal Khan, Sr Research Officer-Knowledge Management R&D, SRL gives an outlook on the burgeoning morbidity and mortality…
Patent protection for orphan drugs
With the increase in orphan drug registrations and high revenue potential prediction; it has become crucial for companies to…
Jubilant Life Sciences’ consolidated revenue up nine per cent Y-o-Y
EBITDA margins reported at 17.5 per cent
Strides Arcolab receives ANDA approval from USFDA for treatment of HIV-1 infection in adults
Approval under the PEPFAR scheme, total PEPFAR approvals at 20
Lupin receives US FDA approval for for treatment of chronic angina
Ranexa tablets, 500 mg and 1000 mg had US sales of approximately $ 443.4 million
Glenmark’s consolidated revenue increases by 18.98 per cent to Rs 12,378.82 million for Q1 FY 13-14
Consolidated Net Profit increased by 64.38 per cent to Rs. 1286.76 million in Q1 FY13-14
Clinical trials in India in a crisis: Does it matter?
Dr Prem Pais, Head, Division of Clinical Research and Training, St John’s Research Institute, Bangalore, makes a powerful case for…
Cheaper anti-cancer drug effective in treating most common cause of blindness in older adults
Two drug treatments Lucentis and Avastin are equally effective in treating neovascular or wet age-related macular degeneration
SC asks centre to discuss clinical trial regulation with state/ UT health authorities
PIL petitioners to submit suggestions in two weeks; ISCR expresses concerns on slowdown of trial approvals